MoonLake Immunotherapeutics CFO Matthias Bodenstedt's 2022 pay jumps 640% to $5.7M
MoonLake Immunotherapeutics reports 2022 executive compensation
By ExecPay News
Published: April 26, 2023
MoonLake Immunotherapeutics reported fiscal year 2022 executive compensation information on April 26, 2023.
In 2022, three executives at MoonLake Immunotherapeutics received on average a compensation package of $4.9M, a 34% increase compared to previous year.
Average pay of disclosed executives at MoonLake Immunotherapeutics
Matthias Bodenstedt, Chief Financial Officer, received $5.7M in total, which increased by 640% compared to 2021. 89% of Bodenstedt's compensation, or $5M, was in stock awards. Bodenstedt also received $244K in bonus, $23K of change in pension value and nonqualified deferred compensation earnings, $325K in salary, as well as $20K in other compensation.
Kristian Reich, Chief Scientific Officer, received a compensation package of $4.6M, which decreased by 12% compared to previous year. 74% of the compensation package, or $3.4M, was in stock awards.
Jorge Santos da Silva, Chief Executive Officer, earned $4.5M in 2022, a 11% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2023.